Re:Eloquis: Early in the market and targeted the wrong custo...
by hbosch on Friday January 26, 2018 @02:00PM
(#16241905)
I don't know if there is a lot of useful information to glean from this post, but I did enjoy guessing about a few things that were (domain) name-related.
Under "What would you do differently?"
> I would definitely not put a lot of emphasis on domain name or invest a lot of money without researching the potential of the name.
I was tickled by this, because at the outset I was actually interested in reading an article about the failure of a highly-marketed blood thinner of the (almost exact) same name. I guess this guy probably learned it's hard to win mindshare & SEO points when you're up against Pfizer, who owns Eliquis.com.
Under "What would you do differently?"
> I would definitely not put a lot of emphasis on domain name or invest a lot of money without researching the potential of the name.
I was tickled by this, because at the outset I was actually interested in reading an article about the failure of a highly-marketed blood thinner of the (almost exact) same name. I guess this guy probably learned it's hard to win mindshare & SEO points when you're up against Pfizer, who owns Eliquis.com.